Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007

被引：9

作者：

Seifert, Robert ^{[1
]}

Schafigh, Darius ^{[2
]}

Boegemann, Martin ^{[3
]}

Weckesser, Matthias ^{[1
]}

Rahbar, Kambiz ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Nucl Med, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany

[2] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany

[3] Univ Hosp Munster, Dept Urol, Munster, Germany

来源：

CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 06期

关键词：

PSMA PET/CT; prostate cancer; local relapse; PSMA;

D O I：

10.1097/RLU.0000000000002543

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate-specific membrane antigen (PSMA)-targeted PET/CT has become a fundamental tool in the management of patients with prostate cancer, especially to rule out local recurrence after surgery or radiation. However, the assessment of the prostatic fossa is difficult due to the renal excretion of PSMA-targeted radionuclides. PET/CT studies using Ga-68-PSMA-11 PET/CT and F-18-PSMA-1007 of a 61-year-old man after radical prostatectomy are presented. This case illustrates that F-18-PSMA-1007 is an ideal radionuclide for the detection of local recurrence of prostate cancer and is superior to Ga-68-PSMA-11, especially in case of pelvic lesions.

引用

页码：E394 / E395

页数：2

共 50 条

[1] Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
Hvittfeldt, Erland
Bjoersdorff, Mimmi
Brolin, Gustav
Minarik, David
Svegborn, Sigrid L.
Oddstig, Jenny
Tragardh, Elin
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2022, 42 (06) : 443 - 452
[2] Skeletal 18F-PSMA-1007 uptake in prostate cancer patients
Janssen, Jorinde
Noordzij, Walter
Velleman, Ton
de Jong, Igle Jan
Langendijk, Johannes A.
Verzijlbergen, J. Fred
Stormezand, Gilles N.
Aluwini, Shafak
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[3] Diagnostic Efficacy of 18F-PSMA-1007 in Staging of Prostate Cancer
Gourevich, K.
Koskosi, A.
Keidar, Z.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S598 - S598
[4] 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
Christos Sachpekidis
A. Afshar-Oromieh
K. Kopka
D. S. Strauss
L. Pan
U. Haberkorn
A. Dimitrakopoulou-Strauss
European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 592 - 602
[5] 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
Sachpekidis, Christos
Afshar-Oromieh, A.
Kopka, K.
Strauss, D. S.
Pan, L.
Haberkorn, U.
Dimitrakopoulou-Strauss, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 592 - 602
[6] 18F-PSMA-1007 PET/MR value for the detection of bone metastasis in prostate cancer
Xu, Yuanfan
Wang, Fangxiao
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[7] Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
Prive, Bastiaan M.
Israel, Bas
Janssen, Marcel J. R.
van der Leest, Marloes M. G.
de Rooij, Maarten
van Ipenburg, Jolique A.
Jonker, Marianne
Peters, Steffie M. B.
de Groot, Michel
Zamecnik, Patrik
Hoepping, Alexander
Bomers, Joyce G.
Gotthardt, Martin
Sedelaar, J. P. Michiel
Barentsz, Jelle O.
van Oort, Inge M.
Nagarajah, James
RADIOLOGY, 2024, 311 (02)
[8] Initial Results with 18F-PSMA-1007 in Prostate Cancer Patients with Biochemical Recurrence
Giesel, F. L.
Will, L.
Cardinale, J.
Neels, O. C.
Radtke, J. P.
Kopka, K.
Haberkorn, U.
Kratochwil, C.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S369 - S369
[9] Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT
Ji, Xiaowei
Wang, Ling
Lin, Jie
Tang, Kun
CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E74 - E76
[10] A Comparison of 18F-PSMA-1007 and 64Cu-PSMA in 2 Patients With Metastatic Prostate Cancer
Cardoza-Ochoa, David R.
Rivera-Bravo, Belen
CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E120 - E122

← 1 2 3 4 5 →